City Latest Deals

pills drugs pharmaceutical pharmaceuticals pharma medicine

Pharmaceutical consolidation: trio of US firms win roles on CVS acquisition of Omnicare

21-May-2015 | By Rachel Moloney

Dechert, Sullivan & Cromwell and White & Case have all taken roles in the $12.7bn pharmaceutical deal between US pharmacy chains CVS Health and Omnicare. 

digital world internet

Covington, Latham, Mayer Brown lead on Altice’s acquisition of Suddenlink

21-May-2015 | By Rachel Moloney

Covington & Burling, Latham & Watkins, Mayer Brown and French firm Franklin are among the firms advising in Altice’s acquisition of US rival Suddenlink, in a deal valued at $9.1bn (£5.86m)

London

BLP gains new AIM client as it advises on Stride Gaming's $103m IPO

20-May-2015 | By Rachel Moloney

Berwin Leighton Paisner (BLP) is advising new client Stride Gaming on its $103m (£66m) initial public offering on the Aim market. 

pills drugs pharmaceutical pharmaceuticals pharma medicine

Skadden and Ropes pick up lead roles on Endo's $8bn acquisition of rival Par

19-May-2015 | By Rachel Moloney

Skadden Arps Slate Meagher & Flom and Ropes & Gray have advised Endo International on its $8.05bn acquisition of rival Par Pharmaceutical Holdings. 

Beer drinkers

Hogan Lovells and DLA Piper scoop top roles on Meantime sale to SABMiller

18-May-2015 | By Rachel Moloney

Hogan Lovells and DLA Piper have won top roles on the sale of London craft brewer Meantime Brewing Company to SABMiller.

More from City Latest Deals